Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
2017
Mitochondria and Epigenetics – Crosstalk in Homeostasis and Stress
2017
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism
2015
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
2016
Oncometabolites: linking altered metabolism with cancer
2013
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
2017 StandoutNobel
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Hereditary Kidney Cancer Syndromes
2013
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases
2018
Macrophages in immunoregulation and therapeutics
2023 Standout
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
2019 Nature
Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis
2015
Unsuspected task for an old team: Succinate, fumarate and other Krebs cycle acids in metabolic remodeling
2014
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
2-Oxoglutarate-dependent dioxygenases in cancer
2020 Nobel
High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma
2014
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Targeting proteinase-activated receptors: therapeutic potential and challenges
2012
Oxidative Stress in Cancer
2020 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
2015
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process
2015
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Renal cell carcinoma
2017 Standout
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
Research into cancer metabolomics: Towards a clinical metamorphosis
2015
Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
2018
Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans
2023 StandoutNobel
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Fundamentals of cancer metabolism
2016 Standout
New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas
2017
PHD2 inactivation in Type I cells drives HIF‐2α‐dependent multilineage hyperplasia and the formation of paraganglioma‐like carotid bodies
2018 StandoutNobel
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
2019 StandoutNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Clinical significance of T cell metabolic reprogramming in cancer
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition
2015
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
2014
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of Céline Loriot being referenced
Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations
2012
Kallikrein-Related Peptidase 14 Acts on Proteinase-Activated Receptor 2 to Induce Signaling Pathway in Colon Cancer Cells
2011
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
2012
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
2013